Evidence map›Paper›PMID 27139488›Full record

ArticleThe Journal of experimental medicine2016

Single-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafish.

Finola E Moore, Elaine G Garcia, Riadh Lobbardi, Esha Jain, Qin Tang, John C Moore, Mauricio Cortes, Aleksey Molodtsov, Melissa Kasheta, Christina C Luo and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Zebrafish Thrombocyte Transcriptome Analysis and Functional Genomics.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. Article
  9. Direct male development in chromosomally ZZ zebrafish.Frontiers in cell and developmental biology · 2024
    Article
  10. Transgenic IDH2Oncogene · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. In vivo impact of JAK3 A573V mutation revealed using zebrafish.Cellular and molecular life sciences : CMLS · 2022
    Article
  19. Generation and Characterization of a Zebrafish IL-2Rγc SCID Model.International journal of molecular sciences · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Finola E MooreMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129 dlangenau@mgh.harvard.edu femoore@mgh.harvard.edu.
Elaine G GarciaMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
Riadh LobbardiMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
Esha JainCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114.
Qin TangMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
John C MooreMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
Mauricio CortesDepartment of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115.
Aleksey MolodtsovMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
Melissa KashetaProgram in Molecular Medicine and Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
Christina C LuoMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
Amaris J GarciaMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
Ravi MylvaganamMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
Jeffrey A YoderDepartment of Molecular Biomedical Sciences, North Carolina State University, Raleigh, NC 27607.
Jessica S BlackburnDepartment of Pathology, University of Kentucky College of Medicine, Lexington, KY 40536 Department of Biochemistry, University of Kentucky College of Medicine, Lexington, KY 40536 Department of Molecular Biology, University of Kentucky College of Medicine, Lexington, KY 40536 Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, KY 40536.
Ruslan I SadreyevDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114 Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Craig J CeolProgram in Molecular Medicine and Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
Trista E NorthDepartment of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115.
David M LangenauMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129 Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129 Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114 Harvard Stem Cell Institute, Cambridge, MA 02139 dlangenau@mgh.harvard.edu femoore@mgh.harvard.edu.
Massachusetts General Hospital · USUniversity of Massachusetts Chan Medical School · USBeth Israel Deaconess Medical Center · USHarvard University · USNorth Carolina State University · USUniversity of Kentucky · US

Funding

Immune Compromises Zebrafish for Cell TransplantationR24OD016761 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2013 to 2021
$5.2M
Metabolic regulation of hematopoietic stem cell specification and functionR01DK098241 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI NORTH, TRISTA E. · 2014 to 2018
$2.0M
Use of comparative genomics to identify novel regulators of melanoma progressionR01AR063850 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CEOL, CRAIG JOSEPH · 2013 to 2017
$1.8M
Translational Immunology Core's FACSAria Cell SorterS10RR023440 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI PREFFER, FREDERIC IRA · 2008 to 2008
$500k
The Role of Phf6 in HematopoiesisF32DK098875 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MOORE, FINOLA ELIZABETH · 2013 to 2015
$165k
NCRR NIH HHS S10 RR023440NIDDK NIH HHS F32 DK098875NIH HHS R24 OD016761
6 · The paper itself

Abstract

Hematopoiesis culminates in the production of functionally heterogeneous blood cell types. In zebrafish, the lack of cell surface antibodies has compelled researchers to use fluorescent transgenic reporter lines to label specific blood cell fractions. However, these approaches are limited by the availability of transgenic lines and fluorescent protein combinations that can be distinguished. Here, we have transcriptionally profiled single hematopoietic cells from zebrafish to define erythroid, myeloid, B, and T cell lineages. We also used our approach to identify hematopoietic stem and progenitor cells and a novel NK-lysin 4(+) cell type, representing a putative cytotoxic T/NK cell. Our platform also quantified hematopoietic defects in rag2(E450fs) mutant fish and showed that these fish have reduced T cells with a subsequent expansion of NK-lysin 4(+) cells and myeloid cells. These data suggest compensatory regulation of the innate immune system in rag2(E450fs) mutant zebrafish. Finally, analysis of Myc-induced T cell acute lymphoblastic leukemia showed that cells are arrested at the CD4(+)/CD8(+) cortical thymocyte stage and that a subset of leukemia cells inappropriately reexpress stem cell genes, including bmi1 and cmyb In total, our experiments provide new tools and biological insights into single-cell heterogeneity found in zebrafish blood and leukemia.

Indexed as

Amino Acid SubstitutionAnimalsDNA-Binding ProteinsHematopoiesisHematopoietic Stem CellsKiller Cells, NaturalMutation, MissenseNeoplastic Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesTranscription, GeneticZebrafishZebrafish ProteinsDNA-Binding ProteinsRAG2 protein, zebrafishZebrafish Proteins

Identifiers

PMID27139488
PMCPMC4886368
OpenAlexW2347041051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.